ISPH Stock Overview
Ibnsina Pharma operates as a pharmaceutical distributor in Egypt.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 1/6 |
Rewards
Risk Analysis
Ibnsina Pharma Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ج.م2.90 |
| 52 Week High | ج.م4.15 |
| 52 Week Low | ج.م1.43 |
| Beta | 0.29 |
| 1 Month Change | 9.02% |
| 3 Month Change | -11.59% |
| 1 Year Change | 102.51% |
| 3 Year Change | -12.12% |
| 5 Year Change | -64.77% |
| Change since IPO | -33.16% |
Recent News & Updates
Recent updates
Shareholder Returns
| ISPH | EG Healthcare | EG Market | |
|---|---|---|---|
| 7D | 3.2% | 5.6% | -0.07% |
| 1Y | 102.5% | 43.7% | 62.3% |
Return vs Industry: ISPH exceeded the EG Healthcare industry which returned 43.7% over the past year.
Return vs Market: ISPH exceeded the EG Market which returned 62.3% over the past year.
Price Volatility
| ISPH volatility | |
|---|---|
| ISPH Average Weekly Movement | 10.1% |
| Healthcare Industry Average Movement | 6.3% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in EG Market | 13.2% |
| 10% least volatile stocks in EG Market | 4.7% |
Stable Share Price: ISPH's share price has been volatile over the past 3 months.
Volatility Over Time: ISPH's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | n/a | Mohamed Mohsen Mahgoub | www.ibnsina-pharma.com |
Ibnsina Pharma operates as a pharmaceutical distributor in Egypt. The company offers pharmaceutical and cosmetics products to private and public-sector customers, including retail chains, independent pharmacies, wholesalers, and hospitals and healthcare institutions. It also provides warehousing and logistic services for its suppliers; marketing solutions; importation and packaging services; and market research and analysis services.
Ibnsina Pharma Fundamentals Summary
| ISPH fundamental statistics | |
|---|---|
| Market cap | ج.م2.92b |
| Earnings (TTM) | ج.م173.14m |
| Revenue (TTM) | ج.م33.95b |
16.9x
P/E Ratio0.1x
P/S RatioIs ISPH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ISPH income statement (TTM) | |
|---|---|
| Revenue | ج.م33.95b |
| Cost of Revenue | ج.م31.43b |
| Gross Profit | ج.م2.52b |
| Other Expenses | ج.م2.34b |
| Earnings | ج.م173.14m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.17 |
| Gross Margin | 7.41% |
| Net Profit Margin | 0.51% |
| Debt/Equity Ratio | 855.3% |
How did ISPH perform over the long term?
See historical performance and comparison